Development of a Synthesis of Kinase Inhibitor AKN028
Author:
Affiliation:
1. Recipharm OT Chemistry, Virdings Allé 32 B, SE 754 50 Uppsala, Sweden
2. R&D Department, Magle Chemoswed, P.O. Box 839, SE 201 80 Malmö, Sweden
Publisher
American Chemical Society (ACS)
Subject
Organic Chemistry,Physical and Theoretical Chemistry
Link
https://pubs.acs.org/doi/pdf/10.1021/acs.oprd.8b00092
Reference11 articles.
1. The novel tyrosine kinase inhibitor AKN-028 has significant antileukemic activity in cell lines and primary cultures of acute myeloid leukemia
2. AKN-028 induces cell cycle arrest, downregulation of Myc associated genes and dose dependent reduction of tyrosine kinase activity in acute myeloid leukemia
3. Jenmalm-Jensen, A.; Lehmann, F.; Nilsson, B. M.; Nordling, E.; Parrow, V. Pyrazine derivatives and their use as protein kinase inhibitors. PCT Int. Appl. WO/2009095399, July 6, 2009.
4. Lehmann, F.; Bremberg, U.; Sölver, E.; Eriksson-Bajtner, J.; Thornqvist-Oltner, V. Processes for manufacturing of a kinase inhibitor. PCT Int. Appl. WO/2013089636, June 20, 2013.
5. Discovery, Synthesis, and Characterization of an Orally Bioavailable, Brain Penetrant Inhibitor of Mixed Lineage Kinase 3
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Natural Products–Pyrazine Hybrids: A Review of Developments in Medicinal Chemistry;Molecules;2023-11-05
2. Palladium Extraction Following Metal-Catalyzed Reactions: Recent Advances and Applications in the Pharmaceutical Industry;Organic Process Research & Development;2023-09-06
3. Pyrazine and Phenazine Heterocycles: Platforms for Total Synthesis and Drug Discovery;Molecules;2022-02-07
4. A broadly applicable quantitative relative reactivity model for nucleophilic aromatic substitution (SNAr) using simple descriptors;Chemical Science;2022
5. Pyrazines and Their Benzo Derivatives;Comprehensive Heterocyclic Chemistry IV;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3